Sort
21,453 grants matching “tuberculosis”
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$916,047Smriti Mehra · Tulane University Of Louisiana · R01 · FY2019 · AI
Rapid DPP test for tuberculosis
$915,648Konstantin P Lyashchenko · Chembio Diagnostic Systems, Inc. · R44 · FY2013 · AI
ULTIMATE
$915,292Reinout Van Crevel · Stichting Radboud Universiteit · R01 · FY2019 · AI
Characterization of Signaling Pathways involved in Cell Death and Survival
$915,252Srinivasa M. Srinivasula · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection
$914,927Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2024 · AI
Technology Core
$914,630John D. Aitchison · Seattle Children'S Hospital · U19 · FY2020 · AI
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$914,044Shabaana A. Khader · University Of Chicago · R01 · FY2023 · AI
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$913,527Nitin S Baliga · Institute For Systems Biology · R01 · FY2021 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis
$913,253Megan B Murray · Harvard Medical School · U19 · FY2017 · AI
Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection
$912,893John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2019 · AI
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$912,707Nitin S Baliga · Institute For Systems Biology · R01 · FY2018 · AI
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects
$912,639Michael L Gross · Washington University · R24 · FY2020 · GM
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
$911,002Bryan David Bryson · Massachusetts General Hospital · R01 · FY2024 · AI
Immunotherapeutics and vaccines against anthrax, plague and tularemia
$909,729Zheng W Chen · University Of Illinois At Chicago · U01 · FY2007 · AI
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
$908,865John R. Chan · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Immune Correlates of Protection from TB
$908,608Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2019 · AI
Multivalent DNA vaccine-mediated protection against Tuberculosis
$908,439David B. Weiner · Wistar Institute · R01 · FY2021 · AI
Transporter function of the Mycobacterium tuberculosis PE/PPE proteins
$907,773Christoph Grundner · Seattle Children'S Hospital · R01 · FY2024 · AI
Technology Core
$907,441John D. Aitchison · Seattle Children'S Hospital · U19 · FY2022 · AI
Combatting natural resistance and persistence in non-TB mycobacterial disease
$906,704Thomas Dick · Hackensack University Medical Center · R01 · FY2020 · AI
Combatting natural resistance and persistence in non-TB mycobacterial disease
$906,704Thomas Dick · Hackensack University Medical Center · R01 · FY2022 · AI
Combatting natural resistance and persistence in non-TB mycobacterial disease
$906,704Thomas Dick · Hackensack University Medical Center · R01 · FY2021 · AI
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$906,484Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
$906,325Larry S. Schlesinger · Texas Biomedical Research Institute · R01 · FY2025 · AI
Multi-Drug Resistant Tuberculosis Drugs: Targeting Cell Wall Synthetic Enzymes
$906,176Michael R McNeil · Colorado State University · P01 · FY2008 · AI